A detailed history of One8zero8, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, One8zero8, LLC holds 9,775 shares of ABBV stock, worth $2.29 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
9,775
Previous 9,474 3.18%
Holding current value
$2.29 Million
Previous $1.76 Billion 28.69%
% of portfolio
0.49%
Previous 0.42%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$184.85 - $231.54 $55,639 - $69,693
301 Added 3.18%
9,775 $2.26 Billion
Q2 2025

Aug 12, 2025

SELL
$170.16 - $206.27 $63,810 - $77,351
-375 Reduced 3.81%
9,474 $1.76 Billion
Q1 2025

May 07, 2025

SELL
$169.2 - $216.66 $304,560 - $389,988
-1,800 Reduced 15.45%
9,849 $2.06 Billion
Q4 2024

Feb 10, 2025

BUY
$164.99 - $203.87 $1.92 Million - $2.37 Million
11,649 New
11,649 $2.07 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track One8zero8, LLC Portfolio

Follow One8zero8, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One8zero8, LLC, based on Form 13F filings with the SEC.

News

Stay updated on One8zero8, LLC with notifications on news.